← Open Payments lookup

CONSTANCE HARTHCOCK: Open Payments

NPI 1841665494 · BRANDON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,418 in 80 payments from 17 companies in 2025. Trend: 2023 $364 · 2024 $1,669 · 2025 $1,418

Food & beverage: $1,418
CompanyPaymentsAmount
ABBVIE INC.15$247
Novo Nordisk Inc12$188
Corcept Therapeutics9$178
GlaxoSmithKline, LLC.9$163
Bayer Healthcare Pharmaceuticals Inc.6$103
AstraZeneca Pharmaceuticals LP5$92
Lilly USA, LLC4$85
Esperion Therapeutics, Inc.4$77
PFIZER INC.3$69
Boehringer Ingelheim Pharmaceuticals, Inc.3$58

Products named: Korlym, TRELEGY ELLIPTA, VRAYLAR, Kerendia, FARXIGA, NEXLETOL, UBRELVY, Ozempic.

Industry payments across MS — which companies pay providers there.